Overview

Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the safety and efficacy of YP-P10 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Phase:

Phase 2

Details

Lead Sponsor:

Yuyu Pharma, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions